We are live on
!
Find out more
YIH
Y-Intercept (HK) Portfolio holdings
AUM
$5.05B
1-Year Est. Return
17.89%
This Fund
S&P 500
This Quarter
Est. Return
+8.14%
1 Year Est. Return
+17.89%
3 Year Est. Return
+34.37%
5 Year Est. Return
+20.59%
10 Year Est. Return
–
AUM
$4.09B
AUM Growth
+$2.61B
(+177%)
Cap. Flow
+$2.46B
Cap. Flow
% of AUM
60.1%
Top 10 Holdings %
Top 10 Hldgs %
6.33%
Holding
2,105
New
963
Increased
487
Reduced
137
Closed
518
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$37.8M |
| 2 |
Sarepta Therapeutics
SRPT
|
+$35.1M |
| 3 |
T-Mobile US
TMUS
|
+$30.4M |
| 4 |
Nu Holdings
NU
|
+$27.8M |
| 5 |
Consolidated Edison
ED
|
+$26.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arista Networks
ANET
|
+$17M |
| 2 |
Marvell Technology
MRVL
|
+$16.2M |
| 3 |
NVO
Novo Nordisk
NVO
|
+$16.1M |
| 4 |
ServiceNow
NOW
|
+$13.3M |
| 5 |
Walmart Inc
WMT
|
+$10.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.87% |
| 2 | Industrials | 14.69% |
| 3 | Financials | 14.36% |
| 4 | Healthcare | 12.68% |
| 5 | Consumer Discretionary | 12.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Shift4
FOUR
$4.45B
| $660K | 0.02% |
+6,656
| New | +$580K |
|
|
FBRT
1102
Franklin BSP Realty Trust
FBRT
$580M
| $658K | 0.02% |
61,510
+45,832
| +292% | +$515K |
|
1103
Cellebrite
CLBT
$3.76B
| $657K | 0.02% |
+41,034
| New | +$732K |
|
1104
James Hardie Industries
JHX
$15.2B
| $654K | 0.02% |
+24,337
| New | +$588K |
|
1105
Tetra Tech
TTEK
$8.77B
| $650K | 0.02% |
18,084
-39,444
| -69% | -$1.31M |
|
1106
Oppenheimer Holdings
OPY
$1.18B
| $648K | 0.02% |
+9,858
| New | +$601K |
|
1107
Jefferies Financial Group
JEF
$12.7B
| $648K | 0.02% |
11,849
-52,205
| -82% | -$2.58M |
|
1108
Rogers Corp
ROG
$2.09B
| $644K | 0.02% |
9,398
+6,396
| +213% | +$412K |
|
1109
Verastem
VSTM
$528M
| $643K | 0.02% |
+154,917
| New | +$970K |
|
1110
TripAdvisor
TRIP
$1.7B
| $642K | 0.02% |
49,188
+28,377
| +136% | +$379K |
|
1111
State Street SPDR S&P Dividend ETF
SDY
$22.1B
| $641K | 0.02% |
+4,719
| New | +$626K |
|
1112
CDW
CDW
$18.9B
| $640K | 0.02% |
3,581
-3,877
| -52% | -$658K |
|
1113
iShares Latin America 40 ETF
ILF
$3.73B
| $639K | 0.02% |
+24,399
| New | +$607K |
|
1114
WesBanco
WSBC
$4.02B
| $637K | 0.02% |
+20,136
| New | +$609K |
|
1115
Target Hospitality
TH
$1.43B
| $634K | 0.02% |
+88,987
| New | +$618K |
|
1116
Astronics
ATRO
$3.21B
| $633K | 0.02% |
+22,681
| New | +$530K |
|
1117
VictoryShares Free Cash Flow ETF
VFLO
$8.99B
| $633K | 0.02% |
+17,901
| New | +$602K |
|
1118
Simmons First National
SFNC
$3.39B
| $628K | 0.02% |
33,146
+12,037
| +57% | +$227K |
|
1119
Kemper
KMPR
$1.81B
| $628K | 0.02% |
9,734
-14,947
| -61% | -$925K |
|
1120
iShares MSCI USA Min Vol Factor ETF
USMV
$23.6B
| $626K | 0.02% |
+6,665
| New | +$613K |
|
1121
State Street SPDR S&P Bank ETF
KBE
$1.64B
| $626K | 0.02% |
+11,218
| New | +$584K |
|
1122
Oil-Dri
ODC
$1.43B
| $625K | 0.02% |
+10,594
| New | +$514K |
|
1123
Rollins
ROL
$18.6B
| $625K | 0.02% |
+11,072
| New | +$621K |
|
|
RAL
1124
Ralliant Corp
RAL
$7.5B
| $623K | 0.02% |
+12,838
| New | +$632K |
|
|
HDV
1125
iShares Core High Dividend ETF
HDV
$14.7B
| $621K | 0.02% |
+26,520
| New | +$611K |
|
Similar funds
HSA
O
LFG
JIM
CTC
NL
BPWM
VT
Y-Intercept (HK)'s Q2 2025 Portfolio in Review
As of Q2 2025, Y-Intercept (HK) held 2,105 positions worth $4.09B, up 177% from $1.48B the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.
Y-Intercept (HK) deployed $2.46B of net new capital in Q2 2025, opening 963 new positions and adding to 487 existing holdings. Its largest new stake was Nu Holdings: 2,319,643 shares worth $31.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 19% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Novo Nordisk, an estimated $16.1M trimmed.
- Y-Intercept (HK)'s largest Q2 2025 buy was Nu Holdings: 2,319,643 shares worth $31.8M.
- Y-Intercept (HK) added most to UnitedHealth in Q2 2025, an estimated $37.8M increase.
- Y-Intercept (HK)'s biggest Q2 2025 reduction was Novo Nordisk, cutting an estimated $16.1M.
- Y-Intercept (HK) fully exited Arista Networks in Q2 2025, selling an estimated $17M.
- Y-Intercept (HK)'s ten largest holdings make up 6.3% of its $4.09B portfolio in Q2 2025.
- Y-Intercept (HK) opened 963 new positions and closed 518 in Q2 2025.
- Y-Intercept (HK)'s portfolio value rose 177% quarter-over-quarter to $4.09B.
Based on Y-Intercept (HK)'s 13F filing for Q2 2025, filed 1 Aug 2025.